NI
SRPT icon

Numeric Investors’s Sarepta Therapeutics SRPT Stock Holding History

Numeric Investors’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-20,300
Closed -$557K – 1145
2016
Q4 		$557K Buy
+20,300
New +$815K 0.01% 799
2015
Q1 		– Sell
-13,500
Closed -$195K – 1028
2014
Q4 		$195K Buy
+13,500
New +$229K ﹤0.01% 791

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Numeric Investors's SRPT Position: Q1 2017 in Review

Numeric Investors sold out of Sarepta Therapeutics (SRPT) in Q1 2017, closing a stake of 20,300 shares — an estimated $557K sold.

Numeric Investors first reported a position in SRPT in Q4 2014 and held it in 2 quarters. The position peaked at $557K in Q4 2016. 179 funds tracked by Wall St. Rank hold SRPT as of Q1 2017.

  • Numeric Investors reported no remaining Sarepta Therapeutics position as of Q1 2017 after selling out during the quarter.
  • Numeric Investors sold 20,300 Sarepta Therapeutics shares in Q1 2017, an estimated $557K.
  • Numeric Investors first reported a position in Sarepta Therapeutics in Q4 2014 and held it in 2 quarters.
  • Numeric Investors's Sarepta Therapeutics position peaked at $557K in Q4 2016.
  • 179 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2017.

Based on Numeric Investors's 13F filing for Q1 2017, filed 15 May 2017.